Open AccessSTC1 is a Novel Biomarker Associated with Immune Characteristics and Prognosis of Bladder Cancer
Author(s) -
Jiale Sun,
Xuedong Wei,
Jiawei You,
Wenchang Yue,
Jun Ouyang,
Zhixin Ling,
Jianquan Hou
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s329723
Subject(s) - bladder cancer , immune system , medicine , immunohistochemistry , oncogene , tissue microarray , cancer , cancer research , oncology , immunology , cell cycle
Stanniocalcin-1 (STC1) is a well-studied oncogene that promotes different types of cancer progression. However, the expression status of STC1, the values of STC1 on prognosis, and its immune characteristic in bladder cancer (BLCA) have not been well examined.